Paxil and Pregnancy: New findings on antidepressants and pregnancy
Until recently, antidepressants—especially selective serotonin reuptake inhibitors (SSRIs)—were considered fairly safe for pregnant women. But late last year, citing evidence from several sources, the FDA warned that infants of women who took the SSRI paroxetine (Paxil) during the first trimester had an increased risk of birth defects and might develop transient withdrawal symptoms. Fortunately, studies of other SSRIs and tricyclic antidepressants indicate they are relatively safe, reports the March issue of the Harvard Mental Health Letter.
The FDA warning has many women reconsidering their options, says the Harvard Mental Health Letter. Some may be inclined to avoid all antidepressants during the first third of pregnancy. But the evidence has to be viewed in a larger context: The findings are reason for caution, but not for alarm.